Kenji
Prostate adenocarcinoma
Initial diagnosis: 2018 - 77
years old
In 2018, Kenji was diagnosed with prostate adenocarcinoma. Despite radical surgery and multiple lines of therapy, the cancer progressed over the next four years. Before receiving the Tumor Portrait test, Kenji’s prostate-specific antigen (PSA) level was elevated to 23.0.
|
|
.webp)
.webp)
BostonGene’s Tumor Portrait test revealed key biomarkers associated with a positive response to immunotherapy, including high PD-L1, MSI, and TMB and an immune-enriched tumor microenvironment (TME).
After the initiation of immunotherapy, Kenji’s PSA levels decreased by 90%, and CT scans showed significant improvements.
